Skip to main content
. 2017 Dec 2;17:162. doi: 10.1186/s12871-017-0450-z

Table 5.

Side effects in the four groups

Group
Side effect
Group(P)
(n = 30)
Group(E)
(n = 30)
Group(D)
(n = 30)
Group(D/E)
(n = 30)
p
PONV (%)
IIII&IV
13 (43.3%)* 7 (23.3%) 7 (23.3%) 5 (16.6%) 0.027
Somnolence 1 (3.3%) 1 (3.3%) 2 (6.7%) 3 (10%) 0.225
Pruritus 5 (16.7%) 4 (13.3%) 3 (10%) 3 (10%) 0.390
Dizziness 1 (3.3%) 2 (6.7%) 4 (13.3%) 3 (10%) 0.239
Headache 6 (20%) 3 (10%) 5 (16.7%) 4 (13.3%) 0.907

Data are presented as number (%). Data were analyzed using chi square test and fisher’s exact test. Placebo group (P), Etoricoxib (E), Duloxetine (D), Duloxetine/Etoricoxib (D/E). P < 0.05 is considered significant. *P = 0.024 when compare P and D/E